Liz Kenny

Prognostic Significance of p16 ^INK4A and Human Papillomavirus in Patients With Oropharyngeal Cancer Treated on TROG 02.02 Phase III Trial

Danny Rischin, Richard J. Young, Richard Fisher et al. · Journal of Clinical Oncology · 2010 · 738 citations · Full text

Tirapazamine, Cisplatin, and Radiation Versus Cisplatin and Radiation for Advanced Squamous Cell Carcinoma of the Head and Neck (TROG 02.02, HeadSTART): A Phase III Trial of the Trans-Tasman Radiation Oncology Group

Danny Rischin, Lester J. Peters, Brian O’Sullivan et al. · Journal of Clinical Oncology · 2010 · 370 citations · Full text

Tirapazamine, Cisplatin, and Radiation Versus Fluorouracil, Cisplatin, and Radiation in Patients With Locally Advanced Head and Neck Cancer: A Randomized Phase II Trial of the Trans-Tasman Radiation Oncology Group (TROG 98.02)

Danny Rischin, Lester Peters, Richard Fisher et al. · Journal of Clinical Oncology · 2004 · 249 citations

Short-term androgen suppression and radiotherapy versus intermediate-term androgen suppression and radiotherapy, with or without zoledronic acid, in men with locally advanced prostate cancer (TROG 03.04 RADAR): an open-label, randomised, phase 3 factorial trial

James W. Denham, David Joseph, David S. Lamb et al. · The Lancet Oncology · 2014 · 159 citations

Zoledronic Acid, Urology, Trog 03.04 +6

Implications for clinical staging of metastatic cutaneous squamous carcinoma of the head and neck based on a multicenter study of treatment outcomes

Jennifer L. Andruchow, Michael Veness, Gary J. Morgan et al. · Cancer · 2006 · 148 citations · Full text